|
Volumn 14, Issue , 2002, Pages S1-S5
|
Second international conference on management of erectile dysfunction: New perspectives on treatment
a b c d e f g h i j k l k m n |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
APOMORPHINE;
ATROPINE;
CALCIUM;
CALCIUM CHANNEL;
CHOLESTEROL;
CYCLIC AMP;
CYCLIC GMP;
NITRIC OXIDE;
PAPAVERINE;
PHENTOLAMINE;
PLACEBO;
POTASSIUM;
POTASSIUM CHANNEL;
PROSTAGLANDIN E1;
PROTEIN KINASE;
SILDENAFIL;
TADALAFIL;
TESTOSTERONE;
VARDENAFIL;
VASOACTIVE AGENT;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIAGNOSTIC TEST;
DRUG EFFICACY;
ERECTILE DYSFUNCTION;
HUMAN;
INCIDENCE;
LIBIDO;
MALE;
MEDICAL EDUCATION;
PATHOPHYSIOLOGY;
PATIENT COUNSELING;
PENIS ERECTION;
PENIS PROSTHESIS;
PREVALENCE;
PRIORITY JOURNAL;
PSYCHOTHERAPY;
RISK FACTOR;
SEX THERAPY;
SYNCOPE;
TESTOSTERONE BLOOD LEVEL;
TREATMENT FAILURE;
|
EID: 0036197132
PISSN: 09559930
EISSN: None
Source Type: Journal
DOI: 10.1038/sj/ijir/3900789 Document Type: Article |
Times cited : (4)
|
References (4)
|